MedPath

The Vanderbilt University

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Recruiting
Conditions
Clonal Hematopoiesis
First Posted Date
2024-11-22
Last Posted Date
2024-11-22
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
800
Registration Number
NCT06701214
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules

Not Applicable
Recruiting
Conditions
Lung Neoplasm
First Posted Date
2024-10-15
Last Posted Date
2024-11-07
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
400
Registration Number
NCT06638398
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

Not Applicable
Recruiting
Conditions
Stage I Lung Cancer
Stage II Lung Cancer
Interventions
Procedure: Cryosurgery
Procedure: Robotic Bronchoscopy
Procedure: Bronchoscopy with Biopsy
Procedure: Resection
Procedure: Chest Radiography
Procedure: Computed Tomography
Procedure: Biospecimen Collection
Other: Electronic Health Record Review
First Posted Date
2024-09-19
Last Posted Date
2024-11-08
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
30
Registration Number
NCT06593106
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

Recruiting
Conditions
Sarcoma
Interventions
Other: Surveys
Other: Blood Collection
Other: Saliva Collection
Other: Urine Collection
Other: Stool Collection
Other: Tissue collection
Other: Physical Activity Monitoring
First Posted Date
2024-07-01
Last Posted Date
2024-07-01
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
2100
Registration Number
NCT06482957
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Phase 1
Recruiting
Conditions
Relapsed Myelodysplastic Syndrome
Refractory Myelodysplastic Syndrome
Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Interventions
Drug: Eltanexor
Drug: Venetoclax
Procedure: Bone Marrow Aspiration and Biopsy
Procedure: Biospecimen Collection
First Posted Date
2024-05-06
Last Posted Date
2024-10-17
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
60
Registration Number
NCT06399640
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer

Phase 2
Recruiting
Conditions
Stage I Lung Cancer
Stage II Lung Cancer
Limited Stage Lung Small Cell Carcinoma
Stage III Lung Cancer
Interventions
Drug: Cisplatin
Drug: Carboplatin
Drug: Etoposide
Biological: Pembrolizumab
Procedure: Computed Tomography
Procedure: Positron Emission Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Biospecimen Collection
Radiation: Radiation Therapy
First Posted Date
2023-11-20
Last Posted Date
2024-05-22
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
20
Registration Number
NCT06140407
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

Phase 1
Recruiting
Conditions
Stage IV Lung Cancer
Extensive Stage Lung Small Cell Carcinoma
Interventions
Drug: Carboplatin
Biological: Atezolizumab
Drug: Etoposide
Radiation: Total Body Irradiation
Radiation: Hypofractionated Radiation Therapy
Procedure: Magnetic Resonance Imaging
First Posted Date
2023-10-31
Last Posted Date
2024-06-20
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
18
Registration Number
NCT06110572
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

TBNA vs EBUS-TBNA Plus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

Phase 3
Recruiting
Conditions
Lung Cancer
Interventions
Procedure: Endobronchial ultrasound with transbronchial needle aspiration
Procedure: Bronchoscopy
Procedure: Cryobiopsy
First Posted Date
2023-10-30
Last Posted Date
2024-11-07
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
250
Registration Number
NCT06105801
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

Recruiting
Conditions
Pulmonary Nodule
Interventions
Procedure: Blood collection
Procedure: Chest Computed Tomography
First Posted Date
2023-10-10
Last Posted Date
2024-07-30
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
100
Registration Number
NCT06074133
Locations
🇺🇸

University of Colorado, Aurora, Colorado, United States

🇺🇸

Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States

🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

and more 1 locations

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Phase 4
Recruiting
Conditions
Digestive System Neuroendocrine Tumor G2
Digestive System Neuroendocrine Tumor G1
Pancreatic Neuroendocrine Tumor G2
Metastatic Digestive System Neuroendocrine Neoplasm
Metastatic Malignant Neoplasm in the Liver
Pancreatic Neuroendocrine Tumor G1
Interventions
Procedure: Tumor Debulking
Drug: Lutetium Lu 177 Dotatate
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Drug: Copper Cu 64 Dotatate
Procedure: Positron Emission Tomography
First Posted Date
2023-08-30
Last Posted Date
2024-07-03
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
6
Registration Number
NCT06016855
Locations
🇺🇸

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath